We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Campbell Soup
CPB
$6.94B
| $3.48M | 0.01% |
71,155
+3,264
| +5% | +$159K |
|
502
Vipshop
VIPS
$6.8B
| $3.47M | 0.01% |
220,793
| – | – |
|
503
Lamar Advertising Co
LAMR
$15.8B
| $3.47M | 0.01% |
25,981
+6,300
| +32% | +$769K |
|
504
Synchrony
SYF
$26.1B
| $3.46M | 0.01% |
69,465
-1,310
| -2% | -$63.4K |
|
505
Nutanix
NTNX
$18.4B
| $3.45M | 0.01% |
58,300
+6,500
| +13% | +$357K |
|
506
Teleflex
TFX
$5.82B
| $3.44M | 0.01% |
13,900
+3,400
| +32% | +$794K |
|
|
BLD
507
DELISTED
TopBuild
BLD
| $3.43M | 0.01% |
8,437
+1,500
| +22% | +$605K |
|
508
Toll Brothers
TOL
$14B
| $3.43M | 0.01% |
22,200
-200
| -0.9% | -$27.1K |
|
509
Immunome
IMNM
$3B
| $3.36M | 0.01% |
230,000
| – | – |
|
510
RenaissanceRe
RNR
$13.3B
| $3.35M | 0.01% |
12,300
+1,300
| +12% | +$314K |
|
511
Eastman Chemical
EMN
$8.43B
| $3.35M | 0.01% |
29,900
+6,300
| +27% | +$630K |
|
512
Qiagen
QGEN
$8.93B
| $3.34M | 0.01% |
71,268
+19,347
| +37% | +$882K |
|
513
Rexford Industrial Realty
REXR
$8.12B
| $3.33M | 0.01% |
66,202
+20,700
| +45% | +$1.03M |
|
514
Boston Properties
BXP
$11B
| $3.31M | 0.01% |
41,200
+9,900
| +32% | +$709K |
|
|
EXAS
515
DELISTED
Exact Sciences
EXAS
| $3.31M | 0.01% |
48,600
+9,400
| +24% | +$530K |
|
|
DOCU
516
DocuSign
DOCU
$12.2B
| $3.3M | 0.01% |
53,200
-115,400
| -68% | -$6.47M |
|
517
Jefferies Financial Group
JEF
$12.9B
| $3.29M | 0.01% |
53,403
+14,200
| +36% | +$806K |
|
518
XPO
XPO
$24.7B
| $3.26M | 0.01% |
30,300
+5,300
| +21% | +$593K |
|
519
Southwest Airlines
LUV
$22B
| $3.25M | 0.01% |
109,785
-72
| -0.1% | -$1.99K |
|
520
Lincoln Electric
LECO
$15.5B
| $3.25M | 0.01% |
16,916
| – | – |
|
521
US Foods
USFD
$23.8B
| $3.23M | 0.01% |
52,441
+10,100
| +24% | +$565K |
|
522
Equitable Holdings
EQH
$14.4B
| $3.21M | 0.01% |
76,300
+8,100
| +12% | +$332K |
|
523
F5
FFIV
$23.6B
| $3.19M | 0.01% |
14,500
+3,200
| +28% | +$620K |
|
524
AngloGold Ashanti
AU
$48.1B
| $3.18M | 0.01% |
119,500
+28,000
| +31% | +$804K |
|
525
Insmed
INSM
$27.6B
| $3.18M | 0.01% |
43,581
+8,800
| +25% | +$649K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.